Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPULS: Propranolol for Preoperative Anxiety in Pancreatic Cancer
NCT06145074Phase 2Recruiting
- Sponsor
- Zealand University Hospital
- Start
- Mar 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in anxiety disorder, pancreatic ductal adenocarcinoma (PDAC), sponsored by Zealand University Hospital. Started Mar 2024; status: recruiting.
02
Drugs
propranolol
03
Conditions
anxiety disorderpancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT06145074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06145074.